How S1P3 signaling in astrocytes induced by FTY720 could influence the disease course in MS patients remains to be elucidated but inhibition of SphK1/S1P3 signaling on astrocytes via inhibition of SphK1 activity could result in reduced neuroinflammation. Here, SPHK1 is linked to myeloid sarcoma.